Point Biopharma Global
(NASDAQ) PNT
Point Biopharma Global Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$243.69M
Net Income (TTM)
$96.55M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PNT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Point Biopharma Global
Industry
Biotechnology
Sector
Health CareEmployees
129
CEO
Joe McCann, PhD
Website
www.pointbiopharma.comHeadquarters
Indianapolis, IN 46268, US
PNT Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
55%
Net Income Margin
43%
Return on Equity
26%
Return on Capital
25%
Return on Assets
17%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$226.58M
Operating Income
$125.52M
EBITDA
$127.32M
Operating Cash Flow
$183.52M
Capital Expenditure
$12.77M
Free Cash Flow
$170.75M
Cash & ST Invst.
$525.21M
Total Debt
$0.00
Point Biopharma Global Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.79M
N/A
Gross Profit
$2.79M
N/A
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
129
N/A
Net Income
$24.77M
-3.2%
EBITDA
$34.49M
-43.7%
Quarterly Fundamentals
Net Cash
$328.50M
+12.7%
Accounts Receivable
$9.39M
+5434.9%
Inventory
$4.20M
N/A
Long Term Debt
$8.74M
N/A
Short Term Debt
$1.93M
N/A
Return on Assets
17.00%
N/A
Return on Invested Capital
25.18%
N/A
Free Cash Flow
$34.53M
-15.3%
Operating Cash Flow
$28.13M
-26.0%